Skip to main content
Premium Trial:

Request an Annual Quote

KogeneBiotech PowerChek SARS-CoV-2 S-gene Mutation Detection Kit

KogeneBiotech of South Korea has launched the PowerChek SARS-CoV-2 S-gene Mutation Detection Kit version 1.0, a research-use-only kit designed to detect and discriminate between 12 significant viral variants. Specifically, the kit detects genomic mutations of the receptor binding domain region of the spike protein, and can discriminate variants of concern that originated in the UK (B.1.1.7), South Africa (B.1.351), Japan/Brazil (P.1), and US/California (B.1.427/429); and the variants of interest, classified by WHO, that originated in New York (B.1.525), Brazil (P.2), India (B.1.167 and B.1.167.1/2/3), the company said. The assay can be performed in less than an hour based on SNP detection via one-step multiplex real-time PCR.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.